Sen. Richard Durbin, joined by other Democrats, introduces legislation to provide annual funding increases for biomedical and scientific research at s...
Alkermes opens multiple sclerosis drug Phase 3 trial aiming for a 2018 NDA submission.
FDA accepts an Asana BioSciences IND for ASN002, a novel dual SYK-JAK inhibitor, for treating atopic dermatitis.
The Government Accountability Office says that FDA and the Agriculture Department need to do more work to provide oversight of medically important ant...
FDAs Drug Safety and Risk Management and Anesthetic and Analgesic Drug Products Advisory Committees votes 18 to 8 that that the benefits of reformulat...
Federal Register Notice: FDA extends the comment period for a 1/18 notice regarding a guidance on Considerations in Demonstrating Interchangeability w...
FDA posts ten Office of Management and Budget information collection notices that have been backlogged and now released after a regulatory review by t...
Federal Register Final Order: FDA classifies as a Class 2 (special controls) medical device the continuous glucose monitor secondary display.